Lucid Ultra 128 vs Otofonix Groove

The Lucid Ultra 128 is a premium behind-the-ear prescription hearing aid priced at $5,000, earning an A grade with a SoundScore of 4.4/5 in our lab testing. It ranks #16 of 36 devices in the Prescription Hearing Aid category. Speech performance is a clear strength for the Ultra 128. In our testing, speech in quiet scored a strong 4.3/5, landing 1.03 points above the category average. Speech in noise measured 2.7/5—above the category average by 0.74 points, though mixed in absolute terms. These results suggest the device prioritizes intelligibility in everyday listening situations. The Ultra 128 does show notable weaknesses. Feedback handling scored just 1.7/5, falling 3.01 points below the category average of 4.71/5—a significant gap that prospective buyers should consider. Music streaming measured 2.3/5, slightly below the category average. Own-voice comfort was mixed at 2.9/5, though this sits just above the category norm. The device uses disposable batteries and supports streaming to both iPhone and Android. At this price point, buyers may want to compare against higher-scoring competitors like the Phonak Sphere Infinio (5.0/5) or Oticon Intent (4.85/5). The Lucid Ultra 128 may suit those who prioritize speech clarity in quieter environments and can work with their hearing care provider to manage its feedback limitations.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.